相关实验视频
Updated: Jul 8, 2025

07:36
Isolation of Mouse Coronary Endothelial Cells
Published on: July 3, 2016
11.3K
乌洛科丁2通过调节巨细胞外细胞囊泡来减轻糖尿病冠状动脉微血管功能障碍
Chao Zhu1, Lihua Pan1, Feier Zhou1
1Department of Pharmacology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China.
Biochemical pharmacology
|December 11, 2023
概括
来自巨细胞的甲基醇暴露的小细胞外囊泡在糖尿病中诱导冠状动脉微血管功能障碍 (CMD). 乌洛科丁2 (UCN2) 通过调节巨细胞衍生的囊泡并恢复IL-33水平来保护糖尿病CMD.
科学领域:
- 心血管生物学 心血管生物学
- 代谢性疾病研究研究
- 细胞和分子医学是细胞和分子医学.
背景情况:
- 糖尿病患者由于冠状动脉微血管功能障碍 (CMD) 的冠状动脉疾病死亡率很高.
- 甲基醇 (MGO) 是一种在糖尿病中积累的代谢物,与血管并发症有关.
- 巨细胞及其分泌的细胞外囊泡越来越被认为是糖尿病血管病理学的关键参与者.
研究的目的:
- 为了调查MGO暴露的巨细胞衍生小细胞外囊泡 (sEVs) 是否导致CMD.
- 确定尿皮质素2 (UCN2) 在糖尿病背景下对MGO诱导的CMD的保护作用.
- 阐明在糖尿病CMD和UCN2的治疗作用中涉及阿尔金酶1和IL-33的机制.
主要方法:
- 在小鼠中诱导2型糖尿病,使用高脂肪饮食和 estreptozotocin.
- 用MGO治疗巨细胞和隔离MGO-sEVs来诱导类似于CMD的疾病.
- 药理抑制和遗传淘汰 (IL-33-/-小鼠) 来研究阿根酶1和IL-33的作用.
- 对冠状动脉内皮功能的评估和对SEVs的分子载荷分析.
主要成果:
- MGO-sEVs诱导冠状动脉内皮功能障碍,模仿糖尿病CMD.
- 阿基纳1,从MGO-sEV转移到内皮细胞,受损内皮依赖放松.
- UCN2治疗改善了内皮功能,降低了MGO水平,并防止了MGO-sEVs中阿基因酶1的丰富.
- 在糖尿病小鼠中,UCN2恢复了降低的IL-33水平,这是其保护作用的关键一步,IL-33-/-小鼠证明了这一点.
结论:
- 转基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因
- UCN2通过调节巨细胞sEV载荷并恢复IL-33.3来证明对糖尿病CMD的治疗潜力.
- 向MGO诱导的巨细胞sEV通路和增强IL-33信号传递代表了治疗糖尿病心血管并发症的有希望的策略.
相关概念视频
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Role of ER in the Secretory Pathway
5.4K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.4K

